KupferCMcManusEBerlageN. History of the National Eye Institute: 1968-2000. National Eye Institute, Bethesda, MD. 2009; 235–235.
2.
Diabetic Retinopathy Study Research Group. Diabetic Retinopathy Study: Report 6. Design, methods, and baseline results. Invest Ophthalmol Vis Sci1981; 21: 149–209.
3.
Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol1976; 81: 383–96.
4.
Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy: ETDRS report number 9. Ophthalmology1991; 98: 766–85.
5.
ETDRS Investigators. Aspirin effects on mortality and morbidity in patients with diabetes mellitus. JAMA1992; 268: 1292–300.
6.
Macular Photocoagulation Study Group. Argon laser photocoagulation for senile macular degeneration: results of a randomized clinical trial. Arch Ophthalmol1982; 100: 912–18.
7.
KassMAHeuerDKHigginbothamEJ. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol2002; 120: 701–13.
8.
FineSLHawkinsBS. The investigators’ perspective on the Collaborative Ocular Melanoma Study. Arch Ophthalmol2007; 124: 968–71.
9.
HawkinsBS. The National Institutes of Health and their sponsorship of clinical trials. Controlled Clin Trials1988; 9: 103–06.
